Dysport Therapeutic (abobotulinumtoxina)
pCPA File Number:
21065
Negotiation Status:
Concluded with an LOI
Indication(s):
Lower Limb Spasticity
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals Canada, Inc.
CDA-AMC Project Number:
SR0556-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: